CARSGEN Therapeutics Ltd. is a biopharmaceutical company engaged in the discovery and development of innovative chimeric antigen receptor (CAR) T-cell therapies for cancer treatment.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!